Synonyms: GSK-2398852 | GSK2398852
Compound class:
Antibody
Comment: Dezamizumab (GSK2398852) is an anti-human serum amyloid P component (anti-SAP) monoclonal antibody, that was developed by GlaxoSmithKline as a potential therapy for the rare disease amyloidosis.
|
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
10364 | dezamizumab |
Synonyms |
GSK-2398852 | GSK2398852 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 652 |
Other databases | |
GtoPdb PubChem SID | 249565935 |
Search PubMed clinical trials | dezamizumab |
Search PubMed titles | dezamizumab |
Search PubMed titles/abstracts | dezamizumab |